NMDA Receptor-Dependent Synaptic Depression in Potentiated Synapses of the Anterior Cingulate Cortex of adult Mice.
ACC
LFS
LTD
LTP
NMDA receptors
Synaptic plasticity
synaptic depression
Journal
Molecular pain
ISSN: 1744-8069
Titre abrégé: Mol Pain
Pays: United States
ID NLM: 101242662
Informations de publication
Date de publication:
Historique:
entrez:
24
5
2021
pubmed:
25
5
2021
medline:
14
1
2022
Statut:
ppublish
Résumé
Long-term potentiation (LTP) is an important molecular mechanism for chronic pain in the anterior cingulate cortex (ACC), a key cortical region for pain perception and emotional regulation. Inhibiting ACC LTP via various manipulations or pharmacological treatments blocks chronic pain. Long-term depression (LTD) is another form of synaptic plasticity in the ACC, which is also proved to be involved in the mechanisms of chronic pain. However, less is known about the interactive relationship between LTP and LTD in the ACC. Whether the synaptic depression could be induced after synaptic LTP in the ACC is not clear. In the present study, we used multi-channel field potential recording systems to study synaptic depression after LTP in the ACC of adult mice. We found that low frequency stimulus (LFS: 1 Hz, 15 min) inhibited theta burst stimulation (TBS)-induced LTP at 30 min after the induction of LTP. However, LFS failed to induce depression at 90 min after the induction of LTP. Furthermore, NMDA receptor antagonist AP-5 blocked the induction of synaptic depression after potentiation. The GluN2B-selective antagonist Ro25-6981 also inhibited the phenomenon in the ACC, while the GluN2A-selective antagonist NVP-AAM077 and the GluN2C/D-selective antagonist PPDA and UBP145 had no any significant effect. These results suggest that synaptic LTP can be depressed by LTD in a time dependent manner, and GluN2B-containing NMDA receptors play important roles in this form of synaptic depression.
Identifiants
pubmed: 34024172
doi: 10.1177/17448069211018045
pmc: PMC8141994
doi:
Substances chimiques
Receptors, N-Methyl-D-Aspartate
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17448069211018045Subventions
Organisme : CIHR
ID : PJT-148648
Pays : Canada
Organisme : CIHR
ID : 419286
Pays : Canada
Références
Learn Mem. 1994 Jul-Aug;1(2):129-39
pubmed: 10467591
Neurotherapeutics. 2009 Oct;6(4):693-702
pubmed: 19789073
Neuropsychopharmacology. 2014 Jul;39(8):1955-67
pubmed: 24553731
J Neurosci. 2018 Sep 12;38(37):8060-8070
pubmed: 30054392
Neuron. 1995 Aug;15(2):427-34
pubmed: 7646894
Front Mol Neurosci. 2014 Jul 03;7:62
pubmed: 25071439
Neuron. 2018 May 16;98(4):783-800.e4
pubmed: 29706584
J Neurosci. 2000 Jun 15;20(12):RC81
pubmed: 10827202
Neurosci Lett. 2020 Jan 10;715:134674
pubmed: 31809803
J Biol Chem. 2001 Dec 21;276(51):48108-17
pubmed: 11679581
Mol Brain. 2008 Jun 17;1:2
pubmed: 18803856
Cell Rep. 2020 Nov 10;33(6):108369
pubmed: 33176141
Science. 2010 Dec 3;330(6009):1400-4
pubmed: 21127255
Mol Brain. 2021 Mar 25;14(1):60
pubmed: 33766086
Mol Neurobiol. 2019 Mar;56(3):1694-1706
pubmed: 29916144
J Neurosci. 1999 Oct 1;19(19):8712-9
pubmed: 10493772
Neuropsychopharmacology. 2014 Feb;39(3):625-37
pubmed: 24008353
Mol Brain. 2020 Mar 16;13(1):41
pubmed: 32178709
Cold Spring Harb Perspect Biol. 2012 Jun 01;4(6):
pubmed: 22510460
Nat Rev Neurosci. 2008 May;9(5):387
pubmed: 18401345
Brain Res. 1991 Jul 26;555(1):112-22
pubmed: 1681992
Mol Pain. 2019 Jan-Dec;15:1744806919832718
pubmed: 30717631
J Neurosci. 2017 Aug 30;37(35):8534-8548
pubmed: 28765333
Neurotherapeutics. 2020 Jul;17(3):861-873
pubmed: 32935298
Nat Rev Neurosci. 2010 Jul;11(7):459-73
pubmed: 20559335
Trends Neurosci. 2008 Apr;31(4):199-207
pubmed: 18329111
Eur J Neurosci. 2005 Jul;22(2):485-94
pubmed: 16045501
Nat Neurosci. 2018 Jan;21(1):50-62
pubmed: 29230056
J Neurosci. 2003 Feb 15;23(4):1125-32
pubmed: 12598600
Mol Brain. 2019 Apr 3;12(1):30
pubmed: 30943994
Neuropharmacology. 2018 Nov;142:30-40
pubmed: 29885421
J Neurosci. 2008 Nov 5;28(45):11685-94
pubmed: 18987204
Mol Pain. 2014 Oct 10;10:65
pubmed: 25304256
Nature. 1995 Jun 1;375(6530):400-4
pubmed: 7760933
J Neurosci. 2005 Nov 30;25(48):11107-16
pubmed: 16319310
J Neurosci. 2015 Dec 2;35(48):15971-83
pubmed: 26631477
Nat Rev Neurosci. 2016 Aug;17(8):485-96
pubmed: 27307118
Mol Brain. 2008 Sep 30;1:9
pubmed: 18826591
Science. 2012 Jan 13;335(6065):235-8
pubmed: 22246779
Exp Brain Res. 1994;100(3):437-43
pubmed: 7813681
Mol Pain. 2007 Apr 30;3:11
pubmed: 17470281
Neurosci Lett. 2012 Nov 21;530(2):121-6
pubmed: 23069667
Trends Neurosci. 2016 Mar;39(3):136-145
pubmed: 26878750
J Neurosci. 2012 Aug 15;32(33):11318-29
pubmed: 22895715
Nat Rev Neurosci. 2007 Jun;8(6):413-26
pubmed: 17514195
Cereb Cortex. 2013 Apr;23(4):932-9
pubmed: 22490551
J Neurosci. 2004 Sep 8;24(36):7821-8
pubmed: 15356193
J Neurosci. 1999 Nov 1;19(21):9346-54
pubmed: 10531439
Science. 2004 May 14;304(5673):1021-4
pubmed: 15143284
Rev Neurosci. 2006;17(4):403-13
pubmed: 17139841
J Neurosci. 1999 Nov 15;19(22):9728-38
pubmed: 10559382
Neuron. 2015 Jan 21;85(2):377-89
pubmed: 25556835
Neuron. 2005 Sep 15;47(6):859-72
pubmed: 16157280
J Pharmacol Exp Ther. 2009 Nov;331(2):618-26
pubmed: 19684252
J Neurosci. 2001 Jun 1;21(11):3705-14
pubmed: 11356857